Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Trend Analysis, 2025-2034

Table of Contents

    1. Introduction
        1.1. Report Description
            1.1.1.  Objectives of the Study
            1.1.2.  Market Scope
            1.1.3.  Assumptions
        1.2. Stakeholders
    2. Executive Summary
        2.1. Market Highlights
    3. Research Methodology
        3.1. Overview
            3.1.1.  Data Mining
        3.2. Data Source
            3.2.1.  Primary Source
            3.2.2.  Secondary Source
    4. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Insights
        4.1. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Market Snapshot
        4.2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Dynamics
            4.2.1.  Drivers and Opportunities
                4.2.1.1. Rising Expenditure on Animal Health
                4.2.1.2. Increasing Investment in Facility Expansion
            4.2.2.  Restraints and Challenges
                4.2.2.1. Stringent Regulation
        4.3. Porter’s Five Forces Analysis
            4.3.1.  Bargaining Power of Suppliers (Moderate)
            4.3.2.  Threats of New Entrants: (Low)
            4.3.3.  Bargaining Power of Buyers (Moderate)
            4.3.4.  Threat of Substitute (Moderate)
            4.3.5.  Rivalry among existing firms (High)
        4.4. PESTEL Analysis
        4.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Trends
        4.6. Value Chain Analysis
    5. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type
        5.1. Key Findings
        5.2. Introduction
            5.2.1. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
        5.3. In-House
            5.3.1. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by In-House, by Region, 2020-2034 (USD Billion)
        5.4. Contract Outsourcing
            5.4.1. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Outsourcing, by Region, 2020-2034 (USD Billion)
            5.4.2. Contract Development
                5.4.2.1.  Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Development, by Region, 2020-2034 (USD Billion)
                5.4.2.2. Preclinical Development
                    5.4.2.2.1.  Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Preclinical Development, by Region, 2020-2034 (USD Billion)
                5.4.2.3. Clinical Development
                    5.4.2.3.1.  Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Clinical Development, by Region, 2020-2034 (USD Billion)
            5.4.3. Contract Manufacturing
                5.4.3.1.  Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Manufacturing, by Region, 2020-2034 (USD Billion)
    6. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type
        6.1. Key Findings
        6.2. Introduction
            6.2.1. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
        6.3. Chemical-based API
            6.3.1. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Chemical-based API, by Region, 2020-2034 (USD Billion)
        6.4. Biological API
            6.4.1. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Biological API, by Region, 2020-2034 (USD Billion)
        6.5. HPAPI
            6.5.1. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by HPAPI, by Region, 2020-2034 (USD Billion)
    7. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type
        7.1. Key Findings
        7.2. Introduction
            7.2.1. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
        7.3. Production Animals
            7.3.1. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Production Animals, by Region, 2020-2034 (USD Billion)
        7.4. Companion Animals
            7.4.1. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Companion Animals, by Region, 2020-2034 (USD Billion)
    8. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category
        8.1.  Key Findings
        8.2.  Introduction
            8.2.1. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
        8.3. Antiparasitics
            8.3.1. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Antiparasitics, by Region, 2020-2034 (USD Billion)
        8.4. Anti-infectives
            8.4.1. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Anti-infectives, by Region, 2020-2034 (USD Billion)
        8.5. NSAIDs
            8.5.1. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by NSAIDs, by Region, 2020-2034 (USD Billion)
        8.6. Others
            8.6.1. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Others, by Region, 2020-2034 (USD Billion)
    9. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Geography
        9.1. Key Findings
        9.2. Introduction
            9.2.1. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Assessment, By Geography, 2020-2034 (USD Billion)
        9.3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Europe
            9.3.1. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
            9.3.2. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
            9.3.3. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
            9.3.4. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
            9.3.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – UK
                9.3.5.1. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
                9.3.5.2. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
                9.3.5.3. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
                9.3.5.4. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
            9.3.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – France
                9.3.6.1. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
                9.3.6.2. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
                9.3.6.3. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
                9.3.6.4. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
            9.3.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Germany
                9.3.7.1. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
                9.3.7.2. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
                9.3.7.3. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
                9.3.7.4. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
            9.3.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Italy
                9.3.8.1. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
                9.3.8.2. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
                9.3.8.3. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
                9.3.8.4. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
            9.3.9. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Spain
                9.3.9.1. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
                9.3.9.2. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
                9.3.9.3. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
                9.3.9.4. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
            9.3.10. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Netherlands
                9.3.10.1. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
                9.3.10.2. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
                9.3.10.3. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
                9.3.10.4. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
            9.3.11. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Russia
                9.3.11.1. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
                9.3.11.2. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
                9.3.11.3. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
                9.3.11.4. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
            9.3.12. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Rest of Europe
                9.3.12.1. Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
                9.3.12.2. Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
                9.3.12.3. Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
                9.3.12.4. Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    10. Competitive Landscape
        10.1. Expansion and Acquisition Analysis
            10.1.1. Expansion
            10.1.2. Acquisitions
        10.2. Partnerships/Collaborations/Agreements/Exhibitions
    11. Company Profiles
        11.1. Bayer AG
            11.1.1. Company Overview
            11.1.2. Financial Performance
            11.1.3. Product Benchmarking
            11.1.4. Recent Development
        11.2. Boehringer Ingelheim International GmbH.
            11.2.1. Company Overview
            11.2.2. Financial Performance
            11.2.3. Product Benchmarking
            11.2.4. Recent Development
        11.3. ECO Animal Health Group PLC
            11.3.1. Company Overview
            11.3.2. Financial Performance
            11.3.3. Product Benchmarking
            11.3.4. Recent Development
        11.4. Elanco
            11.4.1. Company Overview
            11.4.2. Financial Performance
            11.4.3. Product Benchmarking
            11.4.4. Recent Development
        11.5. EUROAPI 
            11.5.1. Company Overview
            11.5.2. Financial Performance
            11.5.3. Product Benchmarking
            11.5.4. Recent Development
        11.6. FIS - Fabbrica Italiana Sintetici S.p.A. 
            11.6.1. Company Overview 
            11.6.2. Financial Performance
            11.6.3. Product Benchmarking
            11.6.4. Recent Development
        11.7. Kempex Holland BV 
            11.7.1. Company Overview
            11.7.2. Financial Performance
            11.7.3. Product Benchmarking
            11.7.4. Recent Development
        11.8. MSD Animal Health 
            11.8.1. Company Overview
            11.8.2. Financial Performance
            11.8.3. Product Benchmarking
            11.8.4. Recent Development
        11.9. SUANFARMA S.A
            11.9.1. Company Overview
            11.9.2. Financial Performance
            11.9.3. Product Benchmarking
            11.9.4. Recent Development
        11.10. Zoetis Inc.
            11.10.1. Company Overview
            11.10.2. Financial Performance
            11.10.3. Product Benchmarking
            11.10.4. Recent Development

    List of Tables:

    Table 1 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
    Table 2 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
    Table 3 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
    Table 4 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    Table 5 UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
    Table 6 UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
    Table 7 UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
    Table 8 UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    Table 9 France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
    Table 10 France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
    Table 11 France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
    Table 12 France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    Table 13 Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
    Table 14 Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
    Table 15 Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
    Table 16 Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    Table 17 Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
    Table 18 Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
    Table 19 Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
    Table 20 Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    Table 21 Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
    Table 22 Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
    Table 23 Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
    Table 24 Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    Table 25 Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
    Table 26 Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
    Table 27 Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
    Table 28 Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    Table 29 Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
    Table 30 Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
    Table 31 Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
    Table 32 Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    Table 33 Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
    Table 34 Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
    Table 35 Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
    Table 36 Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)

    List of Figures:

    Figure 1. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, 2020-2034 (USD Billion)
    Figure 2. Integrated Ecosystem
    Figure 3. Research Methodology: Top-Down & Bottom-Up Price
    Figure 4. Market by Geography
    Figure 5. Porter’s Five Forces
    Figure 6. Market by Service Type
    Figure 7. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2024 & 2034 (USD Billion)
    Figure 8. Market by Synthesis Type
    Figure 9. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2024 & 2034 (USD Billion)
    Figure 10. Market by Animal Type
    Figure 11. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2024 & 2034 (USD Billion)
    Figure 12. Market by Therapeutic Category
    Figure 13. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2024 & 2034 (USD Billion)